Condition
Dilated Cardiomyopathies
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Enrolling By Invitation1
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03479580Recruiting
Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry
NCT03527342Enrolling By InvitationPrimary
Sahlgrenska Cardiomyopathy Project
NCT00904982Not ApplicableCompleted
Randomized Trial of Interventions to Improve Warfarin Adherence
NCT02187263Unknown
German Centre for Cardiovascular Research Cardiomyopathy Register
NCT00622102Not ApplicableCompleted
Testing Strategies to Improving Warfarin Adherence
Showing all 5 trials